UA117907C2 - Лікування припинення пологів - Google Patents

Лікування припинення пологів

Info

Publication number
UA117907C2
UA117907C2 UAA201411545A UAA201411545A UA117907C2 UA 117907 C2 UA117907 C2 UA 117907C2 UA A201411545 A UAA201411545 A UA A201411545A UA A201411545 A UAA201411545 A UA A201411545A UA 117907 C2 UA117907 C2 UA 117907C2
Authority
UA
Ukraine
Prior art keywords
treatment
labor
arrest
labor arrest
sulfated
Prior art date
Application number
UAA201411545A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ґунвор Екман-Ордеберг
Андерс Мальмстрьом
Original Assignee
Ділафор Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ділафор Аб filed Critical Ділафор Аб
Publication of UA117907C2 publication Critical patent/UA117907C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
UAA201411545A 2012-03-26 2013-03-25 Лікування припинення пологів UA117907C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615400P 2012-03-26 2012-03-26
PCT/SE2013/050333 WO2013147690A1 (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Publications (1)

Publication Number Publication Date
UA117907C2 true UA117907C2 (uk) 2018-10-25

Family

ID=49260784

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201411545A UA117907C2 (uk) 2012-03-26 2013-03-25 Лікування припинення пологів

Country Status (15)

Country Link
US (1) US20150057226A1 (enExample)
EP (1) EP2830634A4 (enExample)
JP (1) JP2015514705A (enExample)
CN (1) CN104244957B (enExample)
AU (1) AU2013240598A1 (enExample)
CA (1) CA2868479A1 (enExample)
HK (1) HK1203370A1 (enExample)
MX (1) MX2014011451A (enExample)
MY (1) MY185108A (enExample)
NZ (1) NZ631279A (enExample)
RU (1) RU2014143008A (enExample)
SG (1) SG11201406118QA (enExample)
UA (1) UA117907C2 (enExample)
WO (1) WO2013147690A1 (enExample)
ZA (1) ZA201406567B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2794665T3 (da) 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
MY169816A (en) 2012-03-26 2019-05-16 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
US20150099703A1 (en) * 2012-05-08 2015-04-09 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
US12502403B2 (en) 2020-02-17 2025-12-23 Dilafor Ab Tafoxiparin for the treatment of preeclampsia
CA3255831A1 (en) 2022-05-03 2023-11-09 Dilafor Ab NEW MEDICAL USE OF TAFOXIPARIN
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
CN120603543A (zh) * 2023-02-01 2025-09-05 马特纳医疗公司 用于防止分娩期间阴道撕裂伤的方法和设备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000065837A (ja) * 1998-08-24 2000-03-03 Seikagaku Kogyo Co Ltd グリコサミノグリカン又はグリコサミノグリカン結合性分子の測定方法及びその測定用キット
JP2000309544A (ja) * 1999-02-25 2000-11-07 Seikagaku Kogyo Co Ltd 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
DK2794665T3 (da) * 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf

Also Published As

Publication number Publication date
CN104244957A (zh) 2014-12-24
RU2014143008A (ru) 2016-05-20
JP2015514705A (ja) 2015-05-21
CN104244957B (zh) 2017-11-17
AU2013240598A1 (en) 2014-10-02
SG11201406118QA (en) 2014-11-27
EP2830634A1 (en) 2015-02-04
US20150057226A1 (en) 2015-02-26
EP2830634A4 (en) 2016-01-20
CA2868479A1 (en) 2013-10-03
HK1203370A1 (en) 2015-10-30
WO2013147690A1 (en) 2013-10-03
MY185108A (en) 2021-04-30
ZA201406567B (en) 2017-06-28
MX2014011451A (es) 2014-11-10
NZ631279A (en) 2016-06-24

Similar Documents

Publication Publication Date Title
MY185108A (en) Method for treatment of labor arrest
PH12019501197A1 (en) Therapeutically active compounds and their methods of use
MX2015014582A (es) Agentes para regulacion hacia abajo de la actividad y/o cantidad de bcl-xl y/o bcl-w.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
PH12014501997A1 (en) Esketamine for the treatment of treatment-refractory or treatment-resistant depression
PH12016500164B1 (en) Therapeutically active compounds and their methods of use
PH12014501561A1 (en) Therapeutically active compounds and their methods of use
IL239488A0 (en) A gpc3-targeted medicinal agent for the treatment of patients for whom treatment with a gpc3-targeted medicinal agent is beneficial
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12015502042A1 (en) Use of linagliptin in cardio-and renoprotective antidiabetic therapy
MX2015016100A (es) Inhibidores de criopirina para prevenir y tratar la inflamacion.
PH12014502577A1 (en) Compositions comprising an anti-pdgf aptamer and a vegf antagonist
MX364220B (es) Metodos de tratamientos de fibrosis.
HK1223924A1 (zh) 治疗活性化合物及其使用方法
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
MY175743A (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
CL2013003700A1 (es) Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico.
HK1218251A1 (zh) 用拉喹莫德治疗多发性硬化症
PH12015500663A1 (en) Pharmaceutical combinations comprising dual angiopoietin-2/dll4 binders and anti-vegf-r agents
SI3125865T1 (sl) Povezava aktivnih sestavin za lokalno uporabo pri prestrukturiranju spremenjene kožne pregrade ki sledi kožnim boleznim
MX2016001686A (es) Composicion para el tratamiento contra el envejecimiento de la piel.
MX2016005614A (es) Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
IN2014MN02461A (enExample)
MY192330A (en) Treatment of postpartum haemorrhage with chemically modified heapin or heparan sulphate and a uterotonic agent
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.